ニューヨークにおける中皮腫の臨床試験
ニューヨーク内の拠点で、中皮腫に関する11件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Columbia University Irving Medical Center, New York
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07277413Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- NYU Langone Medical Center, New York
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
- Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Consent Only), Commack
- Memorial Sloan Kettering Westchester (Consent Only), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中
30歳〜85歳 · 全性別 · 2026/09/24更新 · NCT06037941A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activites), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06057935Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- New York University Langone Health, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/08更新 · NCT05732831Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
- Perlmutter Cancer Center at NYU Langone Hospital Long Island, Mineola
- David H Koch, Memorial Sloan Kettering Cancer Center, New York
- New york cancer and blood specialists - Oncology, Port Jefferson Station
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT05245500Integrated Cancer Repository for Cancer Research
- C.R. Wood Cancer Center, Glens Falls Hospital, Glens Falls
- Faxton St. Luke's Healthcare, Mohawk Valley, Utica
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- NYU Langone Medical Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695A Study of Sacituzumab Govitecan in People With Mesothelioma
- Memorial Sloan Kettering Cancer Center @ Commack, Commack
- Memorial Sloan Kettering Westchester, Harrison
- Memorial Sloan - Kettering Cancer Center, New York
- 他1件
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/28更新 · NCT06477419Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/02更新 · NCT04665206VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Weill Cornell Medicine, Cornell University (site 126), New York
被験者募集中第1/2相
18歳〜80歳 · 全性別 · 2025/12/11更新 · NCT03556228ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。